The event showcased the combined strengths of the two organizations and their shared vision of building a globally competitive, integrated ADC/XDC CRDMO platform.

WuXi Biologics and WuXi STA have established a joint venture company named WuXi XDC to provide contract development and manufacturing of bioconjugates, including antibody-drug conjugates. WuXi ...

BOSTON & ST. LOUIS--(BUSINESS WIRE)--Omniose, a company developing polysaccharide conjugate vaccines against serious bacterial threats, announced today the expansion of the leadership team to include ...

Thanks to modern therapies, a cancer diagnosis is no longer an automatic death sentence. But many patients still suffer from unwanted side effects and limited efficacy. In a recent Bioconjugate ...

The next editor-in-chief of the American Chemical Society journal Bioconjugate Chemistry will be Vincent M. Rotello, a professor of chemistry with an appointment in the molecular and cellular biology ...